| Medical and Health Sciences | Lifetime | 294 | BE 5 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 100 | BE 2 | 99.69 |
| Clinical Biochemistry | Lifetime | 26 | BE 1 | 99.44 |
| Cardiology and Cardiovascular Medicine | Lifetime | 208 | BE 3 | 99.74 |
| Epidemiology | Lifetime | 465 | BE 8 | 99.41 |
| Medical Physiology | Lifetime | 396 | BE 2 | 99.36 |
| Rheumatology | Lifetime | 209 | BE 4 | 99.17 |
| Nephrology | Lifetime | 173 | BE 5 | 98.69 |
| Ophthalmology | Lifetime | 686 | BE 3 | 86.08 |
| Family Practice | Lifetime | 243 | BE 6 | 64.60 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 172 | BE 1 | 97.05 |
| Clinical Biochemistry | 2021-2025 | 38 | BE 2 | 89.14 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 518 | BE 7 | 92.34 |
| Epidemiology | 2021-2025 | 977 | BE 15 | 89.74 |
| Medical Physiology | 2021-2025 | 698 | BE 6 | 88.88 |
| Clinical Pharmacology | 2021-2025 | 501 | BE 8 | 71.81 |
| Cardiovascular Health and Disease Prevention | Lifetime | 5 | BE 2 | 99.91 |
| Folate and B Vitamins Research | Lifetime | 8 | BE 1 | 99.73 |
| Advanced Glycation End Products research | Lifetime | 8 | BE 1 | 99.75 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 26 | BE 1 | 99.81 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 28 | BE 1 | 99.84 |
| Blood Pressure and Hypertension Studies | Lifetime | 52 | BE 3 | 99.75 |
| Cardiovascular Disease and Adiposity | Lifetime | 45 | BE 1 | 99.65 |
| Esophageal and GI Pathology | Lifetime | 129 | BE 8 | 99.42 |
| Chronic Kidney Disease and Diabetes | Lifetime | 73 | BE 1 | 99.44 |
| Diet and metabolism studies | Lifetime | 305 | BE 6 | 99.34 |
| Thermoregulation and physiological responses | Lifetime | 88 | BE 1 | 98.43 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 330 | BE 1 | 99.04 |
| Diabetes Treatment and Management | Lifetime | 240 | BE 3 | 99.00 |
| Heart Rate Variability and Autonomic Control | Lifetime | 431 | BE 5 | 98.52 |
| Adipose Tissue and Metabolism | Lifetime | 600 | BE 2 | 98.51 |
| Metabolism, Diabetes, and Cancer | Lifetime | 352 | BE 8 | 98.62 |
| Alcohol Consumption and Health Effects | Lifetime | 232 | BE 2 | 98.02 |
| Diabetes Management and Research | Lifetime | 428 | BE 9 | 98.48 |
| Nutritional Studies and Diet | Lifetime | 466 | BE 2 | 98.42 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 278 | BE 3 | 97.33 |
| Lipid metabolism and disorders | Lifetime | 225 | BE 1 | 97.46 |
| Birth, Development, and Health | Lifetime | 991 | BE 9 | 97.58 |
| Pregnancy and preeclampsia studies | Lifetime | 914 | BE 11 | 97.29 |
| Diet, Metabolism, and Disease | Lifetime | 992 | BE 23 | 95.87 |
| GDF15 and Related Biomarkers | Lifetime | 147 | BE 3 | 92.16 |
| Natural Antidiabetic Agents Studies | Lifetime | 824 | BE 2 | 94.06 |
| Cardiac Health and Mental Health | Lifetime | 971 | BE 17 | 94.50 |
| Pharmacology and Obesity Treatment | Lifetime | 586 | BE 12 | 94.16 |
| Apelin-related biomedical research | Lifetime | 320 | BE 3 | 92.21 |
| Menopause: Health Impacts and Treatments | Lifetime | 370 | BE 3 | 94.13 |
| Health, Environment, Cognitive Aging | Lifetime | 943 | BE 9 | 90.05 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 611 | BE 4 | 89.85 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 829 | BE 12 | 86.59 |
| Biomarkers in Disease Mechanisms | Lifetime | 692 | BE 4 | 83.32 |
| Aortic Thrombus and Embolism | Lifetime | 249 | BE 2 | 83.63 |
| Advanced Glycation End Products research | 2021-2025 | 64 | BE 1 | 91.57 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 237 | BE 2 | 92.49 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 300 | BE 1 | 93.36 |
| Nutritional Studies and Diet | 2021-2025 | 633 | BE 2 | 93.19 |
| Cardiac Health and Mental Health | 2021-2025 | 373 | BE 9 | 90.16 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 677 | BE 6 | 90.87 |
| Alcohol Consumption and Health Effects | 2021-2025 | 298 | BE 4 | 89.25 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 455 | BE 5 | 87.96 |
| Diet, Metabolism, and Disease | 2021-2025 | 712 | BE 10 | 84.42 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 460 | BE 1 | 82.27 |
| Diabetes Management and Education | 2021-2025 | 909 | BE 9 | 73.69 |
| Lipid metabolism and disorders | 2021-2025 | 614 | BE 2 | 67.76 |
| Pharmacology and Obesity Treatment | 2021-2025 | 760 | BE 6 | 64.09 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 812 | BE 8 | 63.61 |
| Sodium Intake and Health | 2021-2025 | 833 | BE 5 | 60.44 |
